Press release
New Screening Tool Enhances Early Detection of Mental Health Disorders in Children
Image: https://www.globalnewslines.com/uploads/2025/07/1751967520.jpgA groundbreaking study led by Dr. Claudia Lorena Martinez Higueros [https://draclaudiamartinezhigueros.com/en/] and her team has developed and validated a new screening tool aimed at identifying mental health disorders in children aged 6 to 12. This tool is designed for use by primary care professionals without specialized training in child psychiatry, addressing a critical gap in early mental health detection.
Studies show that between 80% and 90% of mental health problems in children are missed in the primary care setting. Furthermore, retrospective reports suggest that disorders with an early onset during childhood or adolescence are often the most severe and persistent, yet they are the ones that receive the most delayed treatment. This new questionnaire was developed to help close this detection gap and facilitate earlier intervention.
The research was published in Revista Clinica de Medicina de Familia by a team from the Centro de Salud I in Spain, the Instituto de Ciencias Medicas y de la Nutricion Salvador Zubiran, the Universidad Nacional Autonoma de Mexico, and the Hospital Psiquiatrico Infantil Dr. Juan N. Navarro in Mexico.
Key Findings:
Comprehensive Coverage: The questionnaire assesses 10 prevalent mental health disorders in children, encompassing a total of 41 items.
High Reliability: Each disorder demonstrated a Cronbach's alpha coefficient exceeding 0.8, indicating strong internal consistency.
Validated Instrument: The tool underwent three validation phases: content validation by expert judges, a pilot test, and factor analysis, ensuring its effectiveness and reliability.
Dr. Martinez Higueros emphasized the significance of this development, stating, "This screening tool empowers primary care providers to identify mental health concerns early, facilitating timely interventions that can significantly improve children's well-being."
The final instrument was validated for 10 disorders, comprising a total of 41 questions. It demonstrated strong reliability, with a Cronbach's Alpha coefficient higher than 0.8 for each disorder. The tool is designed to screen for the following conditions:
Learning Disorder
Attention Deficit Hyperactivity Disorder (ADHD)
Post-traumatic Stress Disorder
Tic Disorder
Depression
Psychotic Disorder
Language Disorder
Elimination Disorder
Obsessive-Compulsive Disorder
Separation Anxiety
The questionnaire is intended to be completed by a parent or guardian and is based on the internationally recognized criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) and the International Classification of Diseases (ICD-10). Its straightforward structure and relatively short completion time make it a practical tool for busy primary care centers.
About the Research Team:
The study was conducted by a multidisciplinary team comprising:
Dr. Claudia Lorena Martinez Higueros - Family Medicine Physician, Puertollano Health Center, Ciudad Real, Spain
Dr. Marsela Alejandra Alvarez Izazaga - Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico
Dr. M. Eloisa Dickinson Bannack - Department of Family Medicine, National Autonomous University of Mexico
Dr. Edith Padron Solomon - Dr. Juan N. Navarro Child Psychiatric Hospital, Mexico
Media Contact
Company Name: Dr. Claudia Martinez Higueros
Contact Person: Press Office
Email: Send Email [http://www.universalpressrelease.com/?pr=new-screening-tool-enhances-early-detection-of-mental-health-disorders-in-children]
Country: United States
Website: https://draclaudiamartinezhigueros.com/en/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New Screening Tool Enhances Early Detection of Mental Health Disorders in Children here
News-ID: 4096474 • Views: …
More Releases from Getnews

Pik Pak Logistics Unveils New "One Warehouse, Every Channel" Omnichannel Fulfill …
Melbourne, VIC - October 23, 2025 - Pik Pak Logistics, a leading provider of third-party logistics (3PL) services in Australia, today announced the expansion of its omnichannel fulfillment model, "One Warehouse, Every Channel." The model allows e-commerce merchants to manage all fulfillment operations - from Shopify checkouts to electronic data interchange (EDI) orders from major retailers - through a single, unified platform.
Image: https://www.globalnewslines.com/uploads/2025/10/03eacd7bf57b829ee6236a4f9304796f.jpg
The announcement highlights Pik Pak's commitment to streamlining…

Cut from the Same Cloth: Two Brothers Redefine Surgical Excellence in Miami
Image: https://www.globalnewslines.com/uploads/2025/10/07529e519a8098d0444e7053515bcba8.jpg
MIAMI, FL - October 23, 2025 - Two brothers have built a legacy defined by both precision and personality in the competitive world of high-stakes medicine, where they often clash. Dr. Georges and Dr. Mario Samaha, double board-certified plastic surgeons and co-founders of La Clinique Privee, are proving that family can be the foundation for innovation, empathy, and excellence in modern surgery.
From Brotherhood to Breakthroughs
Separated by just two years,…

Tiens 33rd Anniversary Global Grand Celebration: Together We Build a New Chapter …
The 2025 Tiens Global Carnival Night and Tiens Group 33rd Anniversary Celebration Grandly Held
The grand event commenced, gathering nations from around the world. On October 17, 2025, the Tiens Global Carnival Night and Tiens Group 33rd Anniversary Celebration were grandly held at the Tiens International Health Industrial Park. The ceremony welcomed political leaders, Olympic champions, Nobel laureates, business elites, and tens of thousands of partners from 118 countries worldwide, all…

Investors' Exercise Reflects Realized Trust as Quantum Solutions Enters a New Ph …
On October 17, 2025, Quantum Solutions Co., Ltd. announced the large-scale exercise of its 13th Series of Stock Acquisition Rights with Exercise Price Adjustment Clauses.
Following the announcement, some market participants misinterpreted the term "exercise" as "share selling," which led to temporary price volatility.In reality, this event is the exact opposite: a clear vote of confidence from investors who are injecting fresh capital into Quantum's long-term strategy.
This exercise marks the beginning…
More Releases for Disorder
Rising Mental Disorder Cases Drive Expansion Of The Generalized Anxiety Disorder …
The Generalized Anxiety Disorder Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Generalized Anxiety Disorder Market Size and Projected Growth Rate?
The market size for generalized anxiety disorder has seen a stable growth in the past few years. The market is expected to…
Autism Spectrum Disorder Therapeutics Market: "Autism Spectrum Disorder Therapie …
Autism Spectrum Disorder Therapeutics Market Scope:
Key Insights : Autism Spectrum Disorder Therapeutics Market size was valued at USD 1.92 billion in 2022 and is poised to grow from USD 2.07 billion in 2023 to USD 3.77 billion by 2031, growing at a CAGR of 7.80% during the forecast period (2024-2031).
Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/autism-spectrum-disorder-therapeutics-market
In-Depth Exploration of the global Autism Spectrum Disorder Therapeutics …
Bipolar Disorder Therapeutics Market Report 2024 - Bipolar Disorder Market Oppor …
"The Business Research Company recently released a comprehensive report on the Global Bipolar Disorder Therapeutics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Bipolar Disorder Therapeutics Market: Balancing the Mind - Unveiling Breakthroug …
Allied Market Research recently said Bipolar disorder, a mental health condition characterized by extreme shifts in mood and energy levels, affects millions of people worldwide. The quest for effective therapeutics to manage this complex disorder has seen remarkable progress in recent years. This article explores the innovative developments in bipolar disorder therapeutics, shedding light on the path to achieving a harmonious balance for those living with this condition.
♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞…
Anti-Depressant Drugs Market to 2027 - Global Analysis and Forecasts By Depressi …
Anti-depressant drugs is a class of medications which is used to treat major depressive disorder, some anxiety disorders, some chronic pain conditions, and to help manage some addictions. Anti-depressant drugs also reduce symptoms of depressive disorders by correcting chemical imbalances of neurotransmitters in the brain. Chemical imbalances may be responsible for changes in mood and behavior.
Anti-depressant drugs market is anticipated to grow in the forecast period owing to driving factors…
Antidepressant Drugs Market Report 2018: Segmentation by Depressive Disorder (Ma …
Global Antidepressant Drugs market research report provides company profile for Alkermes Plc, Allergan Plc, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms…